Marin H. Kollef

Marin H. Kollef's AcademicInfluence.com Rankings

Marin H. Kollef

Philosophy

#2644

World Rank

#4454

Historical Rank

Logic

#690

World Rank

#1200

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Marin H. Kollef's Degrees

Doctorate Medicine University of California, San Francisco

Why Is Marin H. Kollef Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Marin H. Kollef's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. (1999) (1842)
The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. (2000) (1813)
Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. (2002) (1261)
Delaying the Empiric Treatment of Candida Bloodstream Infection until Positive Blood Culture Results Are Obtained: a Potential Risk Factor for Hospital Mortality (2005) (1226)
Effect of a nursing-implemented sedation protocol on the duration of mechanical ventilation. (1999) (1015)
Epidemiology and outcomes of health-care-associated pneumonia: results from a large US database of culture-positive pneumonia. (2005) (971)
Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. (2002) (942)
The use of continuous i.v. sedation is associated with prolongation of mechanical ventilation. (1998) (941)
Ventilator-associated pneumonia. A multivariate analysis. (1993) (787)
The Epidemiology, Pathogenesis and Treatment of Pseudomonas aeruginosa Infections (2012) (775)
A randomized, controlled trial of protocol-directed versus physician-directed weaning from mechanical ventilation. (1997) (733)
International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia (2017) (653)
Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients. (2000) (617)
Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia. (2003) (616)
Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center* (2003) (579)
The influence of mini-BAL cultures on patient outcomes: implications for the antibiotic management of ventilator-associated pneumonia. (1998) (523)
Pseudomonas aeruginosa Bloodstream Infection: Importance of Appropriate Initial Antimicrobial Treatment (2005) (516)
Experience with a clinical guideline for the treatment of ventilator-associated pneumonia (2001) (504)
Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study. (2012) (502)
Silver-coated endotracheal tubes and incidence of ventilator-associated pneumonia: the NASCENT randomized trial. (2008) (494)
The effect of late-onset ventilator-associated pneumonia in determining patient mortality. (1995) (409)
Increase in Adult Clostridium difficile–related Hospitalizations and Case-Fatality Rate, United States, 2000–2005 (2008) (393)
The importance of fluid management in acute lung injury secondary to septic shock. (2009) (393)
Prevention of hospital-associated pneumonia and ventilator-associated pneumonia (2004) (370)
Tracheobronchial aspiration of gastric contents in critically ill tube-fed patients: Frequency, outcomes, and risk factors (2006) (358)
The prevention of ventilator-associated pneumonia. (1999) (353)
The occurrence of ventilator-associated pneumonia in a community hospital: risk factors and clinical outcomes. (2001) (348)
Health Care-Associated Pneumonia and Community-Acquired Pneumonia: a Single-Center Experience (2007) (347)
Early versus late enteral feeding of mechanically ventilated patients: results of a clinical trial. (2002) (340)
Economic Impact of Ventilator-Associated Pneumonia in a Large Matched Cohort (2012) (328)
Clinical cure and survival in Gram-positive ventilator-associated pneumonia: retrospective analysis of two double-blind studies comparing linezolid with vancomycin (2004) (324)
A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia. (2007) (319)
Antibiotic Resistance in the Intensive Care Unit (2001) (318)
Pneumonia caused by methicillin-resistant Staphylococcus aureus. (2008) (317)
Effect of an education program aimed at reducing the occurrence of ventilator-associated pneumonia* (2002) (315)
Septic shock attributed to Candida infection: importance of empiric therapy and source control. (2012) (313)
A randomized clinical trial of continuous aspiration of subglottic secretions in cardiac surgery patients. (1999) (312)
Acute respiratory distress syndrome. (1995) (310)
Before–after study of a standardized hospital order set for the management of septic shock* (2006) (307)
A randomized controlled trial of an antibiotic discontinuation policy for clinically suspected ventilator-associated pneumonia. (2004) (307)
Clinical characteristics and treatment patterns among patients with ventilator-associated pneumonia. (2006) (306)
The impact of nosocomial infections on patient outcomes following cardiac surgery. (1997) (304)
Scheduled change of antibiotic classes: a strategy to decrease the incidence of ventilator-associated pneumonia. (1997) (299)
The use of noninvasive positive pressure ventilation in the emergency department: results of a randomized clinical trial. (1998) (293)
Mechanical ventilator weaning protocols driven by nonphysician health-care professionals: evidence-based clinical practice guidelines. (2001) (293)
A comparative analysis of patients with early-onset vs late-onset nosocomial pneumonia in the ICU setting. (2000) (291)
Probiotic prophylaxis of ventilator-associated pneumonia: a blinded, randomized, controlled trial. (2010) (290)
Healthcare-associated bloodstream infection: A distinct entity? Insights from a large U.S. database* (2006) (277)
Clinical predictors and outcomes for patients requiring tracheostomy in the intensive care unit. (1999) (276)
The effect of an education program on the incidence of central venous catheter-associated bloodstream infection in a medical ICU. (2004) (270)
An educational intervention to reduce ventilator-associated pneumonia in an integrated health system: a comparison of effects. (2004) (270)
Prevalence and Outcomes of Infection Among Patients in Intensive Care Units in 2017. (2020) (263)
Continuation of a randomized, double-blind, multicenter study of linezolid versus vancomycin in the treatment of patients with nosocomial pneumonia. (2003) (254)
Telavancin versus Vancomycin for Hospital-Acquired Pneumonia due to Gram-positive Pathogens (2011) (246)
Ceftazidime-avibactam versus meropenem in nosocomial pneumonia, including ventilator-associated pneumonia (REPROVE): a randomised, double-blind, phase 3 non-inferiority trial. (2017) (242)
Multi-drug resistance, inappropriate initial antibiotic therapy and mortality in Gram-negative severe sepsis and septic shock: a retrospective cohort study (2014) (235)
Risk factors for ventilator-associated pneumonia: from epidemiology to patient management. (2004) (232)
Why do physicians not follow evidence-based guidelines for preventing ventilator-associated pneumonia?: a survey based on the opinions of an international panel of intensivists. (2002) (230)
Broad-spectrum antimicrobials and the treatment of serious bacterial infections: getting it right up front. (2008) (229)
Predictors of 30-day mortality and hospital costs in patients with ventilator-associated pneumonia attributed to potentially antibiotic-resistant gram-negative bacteria. (2008) (225)
Predictors of mortality for methicillin-resistant Staphylococcus aureus health-care-associated pneumonia: specific evaluation of vancomycin pharmacokinetic indices. (2006) (221)
Patient transport from intensive care increases the risk of developing ventilator-associated pneumonia. (1997) (220)
Empiric Combination Antibiotic Therapy Is Associated with Improved Outcome against Sepsis Due to Gram-Negative Bacteria: a Retrospective Analysis (2010) (216)
Invasive approaches to the diagnosis of ventilator-associated pneumonia: A meta-analysis (2005) (214)
The Safety and Diagnostic Accuracy of Minibronchoalveolar Lavage in Patients with Suspected Ventilator-Associated Pneumonia (1995) (214)
Prediction of infection due to antibiotic-resistant bacteria by select risk factors for health care-associated pneumonia. (2008) (211)
Effect of empirical treatment with moxifloxacin and meropenem vs meropenem on sepsis-related organ dysfunction in patients with severe sepsis: a randomized trial. (2012) (209)
Economic implications of an evidence-based sepsis protocol: Can we improve outcomes and lower costs?* (2007) (208)
Red blood cell transfusion and ventilator-associated pneumonia: A potential link? (2004) (207)
An international multicenter retrospective study of Pseudomonas aeruginosa nosocomial pneumonia: impact of multidrug resistance (2015) (204)
Antibiotic stewardship in the intensive care unit. (2011) (199)
Developing a New, National Approach to Surveillance for Ventilator-Associated Events* (2013) (197)
Mechanical Ventilation with or without 7-Day Circuit Changes (1995) (196)
Linezolid versus vancomycin for Staphylococcus aureus bacteraemia: pooled analysis of randomized studies. (2005) (193)
Risk factors for ICU-acquired pneumonia. (1998) (191)
The role of selective digestive tract decontamination on mortality and respiratory tract infections. A meta-analysis. (1994) (189)
Inadequate treatment of nosocomial infections is associated with certain empiric antibiotic choices (2000) (189)
BLEED: a classification tool to predict outcomes in patients with acute upper and lower gastrointestinal hemorrhage. (1997) (188)
Pleuropulmonary complications of Panton-Valentine leukocidin-positive community-acquired methicillin-resistant Staphylococcus aureus: importance of treatment with antimicrobials inhibiting exotoxin production. (2005) (188)
Improving family communications at the end of life: implications for length of stay in the intensive care unit and resource use. (2003) (188)
Determinants of mortality and multiorgan dysfunction in cardiac surgery patients requiring prolonged mechanical ventilation. (1995) (182)
Reporting of medical errors: An intensive care unit experience (2004) (181)
Silver-coated endotracheal tubes associated with reduced bacterial burden in the lungs of mechanically ventilated dogs. (2002) (179)
Treatment-related risk factors for hospital mortality in Candida bloodstream infections* (2008) (177)
Inappropriate antibiotic therapy in Gram-negative sepsis increases hospital length of stay* (2010) (174)
A randomized trial of 7-day doripenem versus 10-day imipenem-cilastatin for ventilator-associated pneumonia (2012) (172)
Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial. (2020) (170)
Limitations of vancomycin in the management of resistant staphylococcal infections. (2007) (168)
Ceftolozane-tazobactam versus meropenem for treatment of nosocomial pneumonia (ASPECT-NP): a randomised, controlled, double-blind, phase 3, non-inferiority trial. (2019) (165)
Hospital mortality for patients with bacteremia due to Staphylococcus aureus or Pseudomonas aeruginosa. (2004) (159)
Morbidity and cost burden of methicillin-resistant Staphylococcus aureus in early onset ventilator-associated pneumonia (2006) (159)
Global Prospective Epidemiologic and Surveillance Study of Ventilator-Associated Pneumonia due to Pseudomonas aeruginosa* (2014) (158)
Fluconazole prophylaxis in critically ill surgical patients: A meta-analysis* (2005) (155)
Fair Allocation of Intensive Care Unit Resources (1997) (154)
Optimizing antibiotic therapy in the intensive care unit setting (2001) (153)
Clostridium difficile in the Intensive Care Unit: Epidemiology, Costs, and Colonization Pressure (2007) (153)
Early versus late tracheostomy in patients who require prolonged mechanical ventilation. (2000) (152)
Nursing adherence with evidence-based guidelines for preventing ventilator-associated pneumonia* (2003) (152)
Methicillin-resistant Staphylococcus aureus sterile-site infection: The importance of appropriate initial antimicrobial treatment* (2006) (151)
Deep vein thrombosis during prolonged mechanical ventilation despite prophylaxis (2002) (149)
What is ventilator-associated pneumonia and why is it important? (2005) (147)
Analysis of 30-day mortality for clostridium difficile-associated disease in the ICU setting. (2007) (143)
Mechanical ventilation with or without daily changes of in-line suction catheters. (1997) (142)
Delirium as detected by the CAM-ICU predicts restraint use among mechanically ventilated medical patients* (2005) (141)
Implementation of a real-time computerized sepsis alert in nonintensive care unit patients* (2011) (141)
Antimicrobial therapy escalation and hospital mortality among patients with health-care-associated pneumonia: a single-center experience. (2008) (139)
Rationalizing antimicrobial therapy in the ICU: a narrative review (2019) (137)
Validation of a clinical score for assessing the risk of resistant pathogens in patients with pneumonia presenting to the emergency department. (2012) (136)
Non-invasive stroke volume measurement and passive leg raising predict volume responsiveness in medical ICU patients: an observational cohort study (2009) (134)
Secular Trends in Candidemia-Related Hospitalization in the United States, 2000–2005 (2008) (129)
To gown or not to gown: the effect on acquisition of vancomycin-resistant enterococci. (2002) (128)
A Randomized Trial of the Amikacin Fosfomycin Inhalation System for the Adjunctive Therapy of Gram‐Negative Ventilator‐Associated Pneumonia: IASIS Trial (2017) (125)
The impact of comorbidity on mortality following in-hospital diagnosis of tuberculosis. (1998) (124)
Inappropriate empiric antifungal therapy for candidemia in the ICU and hospital resource utilization: a retrospective cohort study (2010) (124)
Strategies to prevent antimicrobial resistance in the intensive care unit (2005) (123)
Fluid balance and cardiac function in septic shock as predictors of hospital mortality (2013) (122)
Transfusion practice and blood stream infections in critically ill patients. (2005) (118)
Reduced burden of bacterial airway colonization with a novel silver-coated endotracheal tube in a randomized multiple-center feasibility study* (2006) (118)
Staphylococcus aureus Nasal Colonization and Subsequent Infection in Intensive Care Unit Patients: Does Methicillin Resistance Matter? (2010) (117)
A randomized clinical trial comparing an extended-use hygroscopic condenser humidifier with heated-water humidification in mechanically ventilated patients. (1998) (117)
A comparison of ventilator-associated pneumonia rates as identified according to the National Healthcare Safety Network and American College of Chest Physicians criteria* (2012) (115)
Cycling empirical antimicrobial agents to prevent emergence of antimicrobial-resistant Gram-negative bacteria among intensive care unit patients (2004) (114)
Health care-associated pneumonia (HCAP): a critical appraisal to improve identification, management, and outcomes--proceedings of the HCAP Summit. (2008) (114)
Short- vs long-duration antibiotic regimens for ventilator-associated pneumonia: a systematic review and meta-analysis. (2013) (113)
Methicillin-resistant Staphylococcus aureus prolongs intensive care unit stay in ventilator-associated pneumonia, despite initially appropriate antibiotic therapy (2006) (113)
Economic Burden of Ventilator-Associated Pneumonia Based on Total Resource Utilization (2008) (113)
A prospective evaluation of ventilator-associated conditions and infection-related ventilator-associated conditions. (2015) (109)
Endotracheal tube intraluminal volume loss among mechanically ventilated patients* (2004) (107)
Do clinical features allow for accurate prediction of fungal pathogenesis in bloodstream infections? Potential implications of the increasing prevalence of non-albicans candidemia (2007) (107)
Antibiotic utilization and outcomes for patients with clinically suspected ventilator-associated pneumonia and negative quantitative BAL culture results. (2005) (107)
Implementing quality improvements in the intensive care unit: Ventilator bundle as an example (2009) (107)
Time to Appropriate Antibiotic Therapy Is an Independent Determinant of Postinfection ICU and Hospital Lengths of Stay in Patients With Sepsis* (2015) (104)
Appraising contemporary strategies to combat multidrug resistant gram-negative bacterial infections--proceedings and data from the Gram-Negative Resistance Summit. (2011) (103)
The acute respiratory distress syndrome. (1995) (103)
Is antibiotic cycling the answer to preventing the emergence of bacterial resistance in the intensive care unit? (2006) (102)
Safety and yield of transbronchial biopsy in mechanically ventilated patients. (1997) (102)
Antimicrobial stewardship in the intensive care unit: advances and obstacles. (2009) (102)
A randomized double-blind trial of iseganan in prevention of ventilator-associated pneumonia. (2006) (100)
Clinically recognized cardiac dysfunction: an independent determinant of mortality among critically ill patients. Is there a role for serial measurement of cardiac troponin I? (1997) (99)
A trial of a real-time alert for clinical deterioration in patients hospitalized on general medical wards. (2013) (96)
Endocrine profiles for outcome prediction from the intensive care unit (1993) (96)
The impact of gender on outcome from mechanical ventilation. (1997) (95)
Impact of previous antibiotic therapy on outcome of Gram-negative severe sepsis* (2011) (93)
Emergency department hyperoxia is associated with increased mortality in mechanically ventilated patients: a cohort study (2018) (91)
A comparison of culture-positive and culture-negative health-care-associated pneumonia. (2010) (91)
Duration of Exposure to Antipseudomonal β‐Lactam Antibiotics in the Critically Ill and Development of New Resistance (2019) (90)
Epidemiology, microbiology and outcomes of healthcare-associated and community-acquired bacteremia: a multicenter cohort study. (2011) (90)
The intensive care medicine research agenda on multidrug-resistant bacteria, antibiotics, and stewardship (2017) (90)
Linezolid for treatment of ventilator-associated pneumonia: A cost-effective alternative to vancomycin* (2004) (90)
Early prediction of septic shock in hospitalized patients. (2010) (88)
Use of Adjunctive Aerosolized Antimicrobial Therapy in the Treatment of Pseudomonas aeruginosa and Acinetobacter baumannii Ventilator-Associated Pneumonia (2012) (86)
A Case-Control Study Assessing the Impact of Nonventilated Hospital-Acquired Pneumonia on Patient Outcomes (2016) (83)
The importance of appropriate initial antibiotic therapy for hospital-acquired infections. (2003) (83)
Antimicrobial de-escalation in critically ill patients: a position statement from a task force of the European Society of Intensive Care Medicine (ESICM) and European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Critically Ill Patients Study Group (ESGCIP) (2019) (82)
How to avoid microaspiration? A key element for the prevention of ventilator-associated pneumonia in intubated ICU patients (2014) (82)
Hospital-wide impact of a standardized order set for the management of bacteremic severe sepsis* (2009) (81)
Is there a role for antibiotic cycling in the intensive care unit? (2001) (80)
Predicting intensive care unit outcome with scoring systems. Underlying concepts and principles. (1994) (80)
Diagnostic implications of soluble triggering receptor expressed on myeloid cells-1 in BAL fluid of patients with pulmonary infiltrates in the ICU. (2009) (80)
Methicillin-resistant Staphylococcus aureus: a new community-acquired pathogen? (2006) (79)
Practice Patterns and Outcomes Associated With Early Sedation Depth in Mechanically Ventilated Patients: A Systematic Review and Meta-Analysis* (2017) (78)
Delays in the Suspicion and Treatment of Tuberculosis among Hospitalized Patients (1999) (78)
Triage considerations for patients with acute gastrointestinal hemorrhage admitted to a medical intensive care unit. (1995) (78)
Effect of kinetic therapy on pulmonary complications. (2004) (77)
Intensity of renal support in critically ill patients with acute kidney injury (New England Journal of Medicine (2008) 359, (7-20)) (2009) (77)
The effect of respiratory therapist-initiated treatment protocols on patient outcomes and resource utilization. (2000) (77)
Noncardiogenic Pulmonary Edema following Upper Airway Obstruction 7 Cases and a Review of the Literature (1991) (77)
The determinants of hospital mortality among patients with septic shock receiving appropriate initial antibiotic treatment* (2012) (77)
An integrated data mining approach to real-time clinical monitoring and deterioration warning (2012) (77)
Using the Number Needed to Treat to Assess Appropriate Antimicrobial Therapy as a Determinant of Outcome in Severe Sepsis and Septic Shock* (2014) (76)
Occurrence of Co-colonization or Co-Infection with Vancomycin-Resistant Enterococci and Methicillin-Resistant Staphylococcus aureus in a Medical Intensive Care Unit (2004) (75)
INCREASE IN CLOSTRIDIUM DIFFICILE-RELATED HOSPITALIZATIONS AMONG INFANTS IN THE UNITED STATES, 2000–2005 (2008) (74)
The management of severe sepsis and septic shock. (2009) (74)
Sepsis-Associated Coagulopathy Severity Predicts Hospital Mortality* (2018) (74)
Hospital Resource Utilization and Costs of Inappropriate Treatment of Candidemia (2010) (74)
Use of Hypochlorite Solution to Decrease Rates of Clostridium difficile-Associated Diarrhea (2007) (74)
Inappropriate therapy for methicillin-resistant Staphylococcus aureus: Resource utilization and cost implications* (2008) (74)
Re-estimating annual deaths due to multidrug-resistant organism infections (2018) (73)
Secular trends in Acinetobacter baumannii resistance in respiratory and blood stream specimens in the United States, 2003 to 2012: A survey study. (2016) (73)
The number of discharge medications predicts thirty-day hospital readmission: a cohort study (2015) (72)
Appropriate empirical antibacterial therapy for nosocomial infections: getting it right the first time. (2003) (71)
Clostridium difficile-associated disease and mortality among the elderly critically ill (2009) (71)
A Cost-Benefit Analysis of Gown Use in Controlling Vancomycin-Resistant Enterococcus Transmission Is It Worth the Price? (2004) (71)
Clostridium difficile in the ICU: the struggle continues. (2011) (70)
A randomized trial of real-time automated clinical deterioration alerts sent to a rapid response team. (2014) (70)
The use of inhaled prostaglandins in patients with ARDS: a systematic review and meta-analysis. (2015) (70)
Cost-Effectiveness Analysis of a Silver-Coated Endotracheal Tube to Reduce the Incidence of Ventilator-Associated Pneumonia (2009) (69)
Challenges in severe community-acquired pneumonia: a point-of-view review (2019) (69)
Growth and Geographic Variation in Hospitalizations with Resistant Infections, United States, 2000–2005 (2008) (69)
Ventilator-Associated Pneumonia in a Multi-Hospital System Differences in Microbiology by Location (2003) (68)
Lung‐Protective Ventilation Initiated in the Emergency Department (LOV‐ED): A Quasi‐Experimental, Before‐After Trial (2017) (68)
Early Palliative Care Consultation in the Medical ICU: A Cluster Randomized Crossover Trial. (2019) (67)
Bacterial and fungal superinfections in critically ill patients with COVID-19 (2020) (67)
A risk score for identifying methicillin-resistant Staphylococcus aureus in patients presenting to the hospital with pneumonia (2013) (67)
Infectious Diseases Consultation Reduces 30-Day and 1-Year All-Cause Mortality for Multidrug-Resistant Organism Infections (2018) (66)
The impact of the introduction of a rapid D-dimer assay on the diagnostic evaluation of suspected pulmonary embolism. (2001) (66)
The alphabet soup of pneumonia: CAP, HAP, HCAP, NHAP, and VAP. (2009) (65)
Cost and mortality prediction using polymerase chain reaction pathogen detection in sepsis: evidence from three observational trials (2010) (65)
Patient safety event reporting in critical care: A study of three intensive care units* (2007) (65)
Health care-associated infection (HAI): a critical appraisal of the emerging threat-proceedings of the HAI Summit. (2008) (63)
Targeted Fluid Minimization Following Initial Resuscitation in Septic Shock: A Pilot Study. (2015) (63)
Probiotics for preventing and treating nosocomial infections: review of current evidence and recommendations. (2007) (62)
Selective digestive decontamination should not be routinely employed. (2003) (62)
Risk factors for the misdiagnosis of pneumothorax in the intensive care unit (1991) (61)
Acquisition of vancomycin-resistant enterococci during scheduled antimicrobial rotation in an intensive care unit. (2001) (61)
Methicillin-resistant Staphylococcus aureus nasal colonization is a poor predictor of intensive care unit-acquired methicillin-resistant Staphylococcus aureus infections requiring antibiotic treatment (2010) (61)
The Epidemiology of Vancomycin-Resistant Enterococcus Colonization in a Medical Intensive Care Unit (2003) (58)
Probiotics for preventing ventilator-associated pneumonia. (2014) (58)
Epidemiology and Outcomes of Hospitalizations with Complicated Skin and Skin-Structure Infections: Implications of Healthcare-Associated Infection Risk Factors (2009) (58)
A rapid assay for the detection of circulating D-dimer is associated with clinical outcomes among critically ill patients. (1998) (57)
EPIDEMIOLOGY AND RISK FACTORS FOR NOSOCOMIAL PNUEMONIA: Emphasis on Prevention (1999) (57)
Pressure Ulcer Incidence in Patients Wearing Nasal-Oral Versus Full-Face Noninvasive Ventilation Masks. (2015) (57)
Clinical utility of blood cultures drawn from central vein catheters and peripheral venipuncture in critically ill medical patients. (2003) (56)
The Epidemiology and Pathogenesis and Treatment of Pseudomonas aeruginosa Infections: An Update (2021) (56)
Hospital-acquired pneumonia and de-escalation of antimicrobial treatment. (2001) (56)
The Importance of Early Treatment With Doxycycline in Human Ehrlichiosis (2008) (56)
Impact of Sepsis Classification and Multidrug-Resistance Status on Outcome Among Patients Treated With Appropriate Therapy* (2015) (56)
The effect of renal replacement therapy and antibiotic dose on antibiotic concentrations in critically ill patients: Data from the multinational SMARRT Study. (2020) (56)
Healthcare-associated pneumonia: diagnostic criteria and distinction from community-acquired pneumonia. (2011) (55)
Telavancin for Hospital-Acquired Pneumonia: Clinical Response and 28-Day Survival (2014) (55)
Private attending physician status and the withdrawal of life-sustaining interventions in a medical intensive care unit population. (1996) (54)
Mechanical Ventilation and ARDS in the ED: A Multicenter, Observational, Prospective, Cross-sectional Study. (2015) (53)
SMART approaches for reducing nosocomial infections in the ICU. (2008) (53)
Using protocols to improve the outcomes of mechanically ventilated patients. Focus on weaning and sedation. (2001) (52)
Resistance to empiric antimicrobial treatment predicts outcome in severe sepsis associated with Gram-negative bacteremia. (2011) (52)
Readmission following hospitalization for pneumonia: the impact of pneumonia type and its implication for hospitals. (2013) (52)
Association between a silver-coated endotracheal tube and reduced mortality in patients with ventilator-associated pneumonia. (2010) (52)
Reducing the duration of mechanical ventilation: three examples of change in the intensive care unit. (1998) (51)
New antimicrobial agents for methicillin-resistant Staphylococcus aureus. (2009) (51)
Diagnosis and management of skin and soft tissue infections in the intensive care unit: a review (2016) (51)
Aerosolized antibiotics: do they add to the treatment of pneumonia? (2013) (51)
Pulmonary infections complicating ARDS (2020) (50)
Physicians' estimates of cardiac index and intravascular volume based on clinical assessment versus transesophageal Doppler measurements obtained by critical care nurses. (2003) (49)
Acute respiratory failure due to extramedullary hematopoiesis. (1995) (49)
The influence of infection on hospital mortality for patients requiring > 48 h of intensive care. (2003) (48)
Epidemiology, Co-Infections, and Outcomes of Viral Pneumonia in Adults (2015) (48)
Viruses are prevalent in non-ventilated hospital-acquired pneumonia (2016) (48)
Activity of a silver-coated endotracheal tube in preclinical models of ventilator-associated pneumonia and a study after extubation* (2010) (46)
Appropriate empiric antimicrobial therapy of nosocomial pneumonia: the role of the carbapenems. (2004) (46)
Hospitalizations with healthcare-associated complicated skin and skin structure infections: impact of inappropriate empiric therapy on outcomes. (2010) (46)
Candidemia on presentation to the hospital: development and validation of a risk score (2009) (46)
Clostridium difficile Infection: A Multicenter Study of Epidemiology and Outcomes in Mechanically Ventilated Patients (2013) (46)
Epidemiology and outcomes of clostridium difficile-associated disease among patients on prolonged acute mechanical ventilation. (2009) (46)
Ventilator-associated tracheobronchitis in a mixed surgical and medical ICU population. (2011) (46)
Epidemiology and risk factors for nosocomial pneumonia. Emphasis on prevention. (1999) (45)
The quick and the dead: the importance of rapid evaluation of infiltrates in the immunocompromised patient. (2002) (45)
Recognition and prevention of nosocomial pneumonia in the intensive care unit and infection control in mechanical ventilation (2010) (45)
Original Research: Critical CareThe Use of Inhaled Prostaglandins in Patients With ARDS (2015) (44)
Predictors of hospital mortality among septic ICU patients with Acinetobacter spp.bacteremia: a cohort study (2014) (44)
Developing a New, National Approach to Surveillance for Ventilator-Associated Events: Executive Summary (2013) (44)
Surveillance for Vancomycin-Resistant Enterococci: Type, Rates, Costs, and Implications (2006) (44)
Antimicrobial therapy of ventilator-associated pneumonia: how to select an appropriate drug regimen. (1999) (44)
Developing a new, national approach to surveillance for ventilator-associated events: executive summary. (2013) (43)
The influence of access to a private attending physician on the withdrawal of life-sustaining therapies in the intensive care unit. (1999) (43)
Medical Data Mining for Early Deterioration Warning in General Hospital Wards (2011) (43)
Health care-associated pneumonia: identification and initial management in the ED. (2008) (43)
Ventilator-Associated Pneumonia: Insights From Recent Clinical Trials (2005) (42)
Prolonged Infusion Antibiotics for Suspected Gram-Negative Infections in the ICU: A Before-After Study (2013) (42)
Predictors of In‐Hospital Mortality for Bloodstream Infections Caused by Enterobacter Species or Citrobacter freundii (2007) (41)
Reversible cardiogenic shock due to chest tube compression of the right ventricle. (1991) (41)
Antimicrobial stewardship programs: mandatory for all ICUs (2012) (41)
Risk factors for acute adverse events during ultrasound-guided central venous cannulation in the emergency department. (2010) (40)
A Quasi-Experimental, Before-After Trial Examining the Impact of an Emergency Department Mechanical Ventilator Protocol on Clinical Outcomes and Lung-Protective Ventilation in Acute Respiratory Distress Syndrome (2017) (40)
Pulmonary involvement in the hypereosinophilic syndrome. (1994) (40)
Incidence of Acute Kidney Injury in Critically Ill Patients Receiving Vancomycin with Concomitant Piperacillin-Tazobactam, Cefepime, or Meropenem (2019) (40)
Analgosedation Practices and the Impact of Sedation Depth on Clinical Outcomes Among Patients Requiring Mechanical Ventilation in the ED: A Cohort Study (2017) (40)
Effects of an Antibiotic Cycling Program on Antibiotic Prescribing Practices in an Intensive Care Unit (2004) (40)
Delayed pleuropulmonary complications following coronary artery revascularization with the internal mammary artery. (1988) (40)
Avoidance of tracheal intubation as a strategy to prevent ventilator-associated pneumonia (1999) (39)
An institutional perspective on the impact of recent antibiotic exposure on length of stay and hospital costs for patients with gram-negative sepsis (2012) (39)
Summary of the international clinical guidelines for the management of hospital-acquired and ventilator-acquired pneumonia (2018) (39)
Using wearable technology to predict health outcomes: a literature review (2018) (39)
Prevention of ventilator-associated pneumonia or ventilator-associated complications: A worthy, yet challenging, goal* (2012) (38)
The accuracy of elevated concentrations of endotoxin in bronchoalveolar lavage fluid for the rapid diagnosis of gram-negative pneumonia. (1996) (38)
A cohort study of bacteremic pneumonia (2016) (38)
Ventilator-Associated Pneumonia (2005) (38)
Using protocols to improve patient outcomes in the intensive care unit: focus on mechanical ventilation and sepsis. (2010) (37)
Optimizing Antibiotic Treatment for Ventilator‐Associated Pneumonia (2006) (36)
Gram-negative bacterial resistance: evolving patterns and treatment paradigms. (2005) (36)
Predicting Resistance to Piperacillin-Tazobactam, Cefepime and Meropenem in Septic Patients With Bloodstream Infection Due to Gram-Negative Bacteria (2017) (36)
Appropriate Empirical Antibacterial Therapy for Nosocomial Infections (2012) (36)
Daily Bathing with Chlorhexidine-Based Soap and the Prevention of Staphylococcus aureus Transmission and Infection (2014) (35)
The carbon footprint of treating patients with septic shock in the intensive care unit. (2018) (35)
Antibiotic use and antibiotic resistance in the intensive care unit: are we curing or creating disease? (1994) (35)
Automated computerized intensive care unit severity of illness measure in the Department of Veterans Affairs: Preliminary results (2000) (35)
Predictive value of a rapid semiquantitative D‐dimer assay in critically ill patients with suspected venous thromboembolic disease (2000) (35)
Health Care-Associated Pneumonia (HCAP): Empiric Antibiotics Targeting Methicillin-Resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa Predict Optimal Outcome (2011) (34)
Levofloxacin for treatment of ventilator-associated pneumonia: a subgroup analysis from a randomized trial. (2005) (34)
Providing appropriate antimicrobial therapy in the intensive care unit: surveillance vs. de-escalation. (2006) (34)
Diagnosis of ventilator-associated pneumonia. (2006) (34)
Treatment of gram - positive infections in critically ill patients (2014) (34)
Toward a two-tier clinical warning system for hospitalized patients. (2011) (34)
Pseudomonas aeruginosa Nosocomial Pneumonia: Impact of Pneumonia Classification (2015) (33)
How to stratify patients at risk for resistant bugs in skin and soft tissue infections? (2016) (33)
Initial antimicrobial management of sepsis (2021) (33)
Ventilator-Associated Pneumonia: The Role of Emerging Diagnostic Technologies (2017) (33)
Impact of antibacterials on subsequent resistance and clinical outcomes in adult patients with viral pneumonia: an opportunity for stewardship (2015) (33)
Preventing ventilator-associated pneumonia: an evidence-based approach of modifiable risk factors. (2006) (32)
Treatment of ventilator-associated pneumonia: get it right from the start. (2003) (32)
Prolonged use of ventilator circuits and ventilator-associated pneumonia: a model for identifying the optimal clinical practice. (1998) (31)
Predictors of Hospital Mortality for Patients with Severe Sepsis Treated with Drotrecogin alfa (activated) (2005) (31)
A Blinded, Randomized, Controlled Trial (2010) (31)
The modified APACHE II score outperforms Curb65 pneumonia severity score as a predictor of 30-day mortality in patients with methicillin-resistant Staphylococcus aureus pneumonia. (2008) (31)
Staphylococcus aureus pneumonia: a "superbug" infection in community and hospital settings. (2005) (31)
Predicting Bacteremia among Patients Hospitalized for Skin and Skin-Structure Infections: Derivation and Validation of a Risk Score (2010) (31)
A Randomized Trial of Conventional Chest Physical Therapy Versus High Frequency Chest Wall Compressions in Intubated and Non-intubated Adults (2012) (30)
Enoxaparin-Associated Dermal Necrosis: A Consequence of Cross-Reactivity with Heparin-Mediated Antibodies (1997) (30)
Outcomes Associated With De‐escalating Therapy for Methicillin‐Resistant Staphylococcus aureus in Culture‐Negative Nosocomial Pneumonia (2019) (30)
Acinetobacter Pneumonia: Improving Outcomes With Early Identification and Appropriate Therapy (2018) (30)
Opinion: The clinical use of selective digestive decontamination (2000) (30)
Labetalol overdose successfully treated with amrinone and alpha-adrenergic receptor agonists. (1994) (30)
The Burden of Viruses in Pneumonia Associated With Acute Respiratory Failure: An Underappreciated Issue (2017) (30)
Pulmonary Mechanics and Mortality in Mechanically Ventilated Patients Without Acute Respiratory Distress Syndrome: A Cohort Study (2017) (30)
The Washington Manual of Critical Care (2007) (30)
Ventilator-associated complications, including infection-related complications: the way forward. (2013) (29)
Rational use of antibiotics in the ICU: balancing stewardship and clinical outcomes. (2014) (29)
Bench-to-bedside review: Antimicrobial utilization strategies aimed at preventing the emergence of bacterial resistance in the intensive care unit (2005) (28)
Clinical implications for patients treated inappropriately for community-acquired pneumonia in the emergency department (2014) (28)
The fat overload syndrome: successful treatment with plasma exchange. (1990) (28)
Attitudes of respiratory therapists and nurses about measures to prevent ventilator-associated pneumonia: a multicenter, cross-sectional survey study. (2007) (28)
Understanding toxic shock syndrome (2015) (27)
The impact of an antibiotic cycling program on empirical therapy for gram-negative infections. (2006) (27)
Early and Adequate Antibiotic Therapy in the Treatment of Severe Sepsis and Septic Shock (2011) (27)
Frequent Versus Infrequent Monitoring of Endotracheal Tube Cuff Pressures (2018) (27)
Endotracheal Tube Misplacement: Incidence, Risk Factors, and Impact of a Quality Improvement Program (1994) (26)
Reducing the Burden of Acute Respiratory Distress Syndrome: The Case for Early Intervention and the Potential Role of the Emergency Department (2014) (26)
Ventilator associated pneumonia in the ICU: where has it gone? (2015) (26)
Diagnostic Utility of Plasma Procalcitonin for Nosocomial Pneumonia in the Intensive Care Unit Setting (2011) (26)
Development and validation of a clinical prediction rule for candidemia in hospitalized patients with severe sepsis and septic shock. (2015) (26)
New antibiotics for community-acquired pneumonia (2019) (26)
Appropriate antibiotic therapy for ventilator-associated pneumonia and sepsis: a necessity, not an issue for debate (2003) (26)
Timing of antibiotic therapy in the ICU (2021) (26)
Use of a handheld computer by respiratory care practitioners to improve the efficiency of weaning patients from mechanical ventilation* (2002) (26)
Pneumonia Pathogen Characterization Is an Independent Determinant of Hospital Readmission (2015) (25)
A descriptive comparison of ultrasound-guided central venous cannulation of the internal jugular vein to landmark-based subclavian vein cannulation. (2010) (25)
Prevention of hospital-acquired pneumonia (2018) (25)
Treatment of severe skin and soft tissue infections: a review (2017) (25)
The ED-SED Study: A Multicenter, Prospective Cohort Study of Practice Patterns and Clinical Outcomes Associated With Emergency Department SEDation for Mechanically Ventilated Patients. (2019) (25)
An empirical approach to the treatment of multidrug-resistant ventilator-associated pneumonia. (2003) (25)
Catheter removal and outcomes of multidrug-resistant central-line-associated bloodstream infection (2018) (25)
Do age and gender influence outcome from mechanical ventilation? (1993) (25)
Addition of vasopressin to norepinephrine as independent predictor of mortality in patients with refractory septic shock: an observational study. (2007) (24)
Utility of transbronchial biopsy in patients with acute respiratory failure: a postmortem study. (1998) (24)
Antibiotic management of ventilator-associated pneumonia due to antibiotic-resistant gram-positive bacterial infection (2005) (24)
Acute respitatory distress syndrome (1996) (24)
Prevention of nosocomial pneumonia in the intensive care unit: beyond the use of bundles. (2011) (24)
Determinants of outcome for patients in the medical intensive care unit requiring abdominal surgery: a prospective, single-center study. (1994) (23)
Mortality and Length of Stay Trends Following Implementation of a Rapid Response System and Real-Time Automated Clinical Deterioration Alerts (2017) (23)
Identifying Critically Ill Patients at Risk for Inappropriate Antibiotic Therapy: A Pilot Study of a Point-of-Care Decision Support Alert* (2014) (22)
Clinical effectiveness of a sedation protocol minimizing benzodiazepine infusions and favoring early dexmedetomidine: a before-after study (2015) (22)
Ventilator-associated pneumonia: an update for clinicians. (1995) (22)
Ventilator-associated pneumonia: clinical considerations. (1994) (22)
A Respiratory Therapist Disease Management Program for Subjects Hospitalized With COPD (2017) (22)
Early tracheostomy--has its time arrived? (2004) (22)
Spot the difference: comparing results of analyses from real patient data and synthetic derivatives (2020) (22)
Quinolones for treatment of nosocomial pneumonia: a meta-analysis. (2005) (21)
Predictors of Outcome in 216 Subjects With ARDS Treated With Inhaled Epoprostenol (2014) (21)
Ventilator-associated pneumonia complicating the acute respiratory distress syndrome. (2001) (21)
Risk Factors and Outcomes for Ineffective Empiric Treatment of Sepsis Caused by Gram-Negative Pathogens: Stratification by Onset of Infection (2017) (21)
Infectious diseases in critical care (2007) (21)
Randomized Controlled Trial to Determine the Impact of Probiotic Administration on Colonization With Multidrug-Resistant Organisms in Critically Ill Patients (2015) (21)
Nosocomial Infection. (2021) (20)
Endotracheal tube-induced sore throat pain and inflammation is coupled to the release of mitochondrial DNA (2017) (20)
Increasing Incidence of Sterile-Site Infections Due to Non-Multidrug-Resistant, Oxacillin-Resistant Staphylococcus aureus Among Hospitalized Patients (2007) (20)
Review of recent clinical trials of hospital-acquired pneumonia and ventilator-associated pneumonia: a perspective from academia. (2010) (20)
Trapped-lung syndrome after cardiac surgery: a potentially preventable complication of pleural injury. (1990) (20)
Cluster analysis to define distinct clinical phenotypes among septic patients with bloodstream infections (2019) (19)
Importance of Site of Infection and Antibiotic Selection in the Treatment of Carbapenem-Resistant Pseudomonas aeruginosa Sepsis (2018) (19)
Time to get serious about infection prevention in the ICU. (2006) (19)
The identification of ICU-specific outcome predictors: a comparison of medical, surgical, and cardiothoracic ICUs from a single institution. (1995) (19)
Monocyte Function and Clinical Outcomes in Febrile and Afebrile Patients With Severe Sepsis (2017) (19)
Surveillance versus clinical adjudication: differences persist with new ventilator-associated event definition. (2015) (19)
Ventilator-associated pneumonia: insights from recent clinical trials. (2005) (19)
Probiotics in the intensive care unit: why controversies and confusion abound (2008) (19)
Occurrence and Predictors of Dexmedetomidine Infusion Intolerance and Failure (2012) (19)
Risk factors for 30-day readmission among patients with culture-positive severe sepsis and septic shock: A retrospective cohort study. (2015) (18)
Antibiotics for the critically ill: more than just selecting appropriate initial therapy (2013) (18)
Enhanced antimicrobial de-escalation for pneumonia in mechanically ventilated patients: a cross-over study (2017) (18)
Ambulatory Care-sensitive Conditions: Clinical Outcomes and Impact on Intensive Care Unit Resource Use (2003) (18)
Update on ventilator-associated pneumonia (2015) (18)
Hemodynamic measurements during a tension pneumothorax. (1994) (18)
A rapid qualitative assay to detect circulating endotoxin can predict the development of multiorgan dysfunction. (1997) (17)
Lung-protective ventilation initiated in the emergency department (LOV-ED): a study protocol for a quasi-experimental, before-after trial aimed at reducing pulmonary complications (2016) (17)
Outcomes associated with bacteremia in the setting of methicillin-resistant Staphylococcus aureus pneumonia: a retrospective cohort study (2015) (16)
Microbiological diagnosis of ventilator-associated pneumonia: using the data to optimize clinical outcomes. (2006) (16)
Chronic pleural effusion following coronary artery revascularization with the internal mammary artery. (1990) (16)
Culture-negative sepsis (2020) (16)
Developing a New, National Approach to Surveillance for Ventilator-Associated Events: Executive Summary (2013) (16)
Is Zero Ventilator-Associated Pneumonia Achievable?: Practical Approaches to Ventilator-Associated Pneumonia Prevention. (2018) (16)
The ED-AWARENESS Study: A Prospective, Observational Cohort Study of Awareness With Paralysis in Mechanically Ventilated Patients Admitted From the Emergency Department (2021) (16)
Readmissions With Multidrug-Resistant Infection in Patients With Prior Multidrug Resistant Infection (2017) (16)
Performance of a Modern Glucose Meter in ICU and General Hospital Inpatients: 3 Years of Real-World Paired Meter and Central Laboratory Results (2017) (15)
A 50-year-old woman with abdominal pain and respiratory failure 3 months after kidney transplantation. (2008) (15)
Management of Severe Sepsis: Integration of Multiple Pharmacologic Interventions (2003) (15)
Endotracheal intubation results in acute tracheal damage induced by mtDNA/TLR9/NF‐κB activity (2018) (15)
Developing a new, national approach to surveillance for ventilator-associated events. (2013) (15)
Recalcitrant chylothorax and chylous ascites associated with hypothyroidism. (1993) (15)
Elaboration of consensus clinical endpoints to evaluate antimicrobial treatment efficacy in future HABP/VABP clinical trials. (2019) (15)
Lung hyperinflation caused by inappropriate ventilation resulting in electromechanical dissociation: a case report. (1992) (15)
Bacteremia increases the risk of death among patients with soft-tissue infections. (2010) (15)
What can be expected from antimicrobial de-escalation in the critically ill? (2013) (15)
Assessment of ceftaroline fosamil in the treatment of community-acquired bacterial pneumonia due to Streptococcus pneumoniae: insights from two randomized trials. (2013) (15)
Hospital Resource Utilization and Costs of Inappropriate Treatment of Candidemia. (2009) (15)
Oral decontamination to prevent ventilator-associated pneumonia: is it a sound strategy? (2009) (14)
Azithromycin and survival in Streptococcus pneumoniae pneumonia: a retrospective study (2013) (14)
Antimicrobial resistance in the ICU: The time for action is now. (2001) (14)
A Randomized Trial of Palliative Care Discussions Linked to an Automated Early Warning System Alert (2017) (14)
Early Deterioration Warning for Hospitalized Patients by Mining Clinical Data (2011) (14)
Moving towards real-time antimicrobial management of ventilator-associated pneumonia. (2007) (14)
Prevention of hospital infection. (2005) (13)
Pulmonary embolism associated with the act of defecation. (1991) (13)
Impact of Time to Appropriate Therapy on Mortality in Patients with Vancomycin-Intermediate Staphylococcus aureus Infection (2016) (13)
Clostridium difficile Recurrence Is a Strong Predictor of 30-Day Rehospitalization Among Patients in Intensive Care (2014) (13)
Predicting outcome from intensive care for patients with rheumatologic diseases. (1992) (13)
Optimizing therapy for MRSA pneumonia. (2007) (13)
Severe hospital-acquired pneumonia: A review for clinicians (2009) (13)
PROBIOTIC PROPHYLAXIS OF VENTILATOR-ASSOCIATED PNEUMONIA (2009) (13)
Factors Associated With Clinical Deterioration Among Patients Hospitalized on the Wards at a Tertiary Cancer Hospital. (2019) (13)
Medical resource utilization among patients with ventilator-associated pneumonia: pooled analysis of randomized studies of doripenem versus comparators (2009) (13)
Health Care-Associated Pneumonia (2010) (12)
Ventilator-associated Pneumonia Prevention. Is It Worth It? (2015) (12)
Prevention of ventilator-associated pneumonia: selecting interventions that make a difference. (2002) (12)
VAT vs VAP: are we heading toward clarity or confusion? (2009) (12)
Dilution Factor of Quantitative Bacterial Cultures Obtained by Bronchoalveolar Lavage in Patients with Ventilator-Associated Bacterial Pneumonia (2017) (12)
A Hypothesis-Generating Study of the Combination of Aspirin plus Macrolides in Patients with Severe Community-Acquired Pneumonia (2018) (12)
qSOFA score: Predictive validity in Enterobacteriaceae bloodstream infections (2018) (12)
Comparison of Sepsis Definitions as Automated Criteria (2021) (12)
Early goal-directed therapy of septic shock: We honestly remain skeptical (2007) (12)
Clinical Effect of Expedited Pathogen Identification and Susceptibility Testing for Gram-Negative Bacteremia and Candidemia by Use of the Accelerate PhenoTM System. (2019) (12)
Association Between Partial Pressure of Arterial Carbon Dioxide and Survival to Hospital Discharge Among Patients Diagnosed With Sepsis in the Emergency Department (2017) (12)
Executive summary: Developing a new, national approach to surveillance for ventilator-associated events. (2013) (12)
Health care-associated pneumonia: perception versus reality. (2009) (12)
Therapeutic Hyperthermia Is Associated With Improved Survival in Afebrile Critically Ill Patients With Sepsis: A Pilot Randomized Trial (2022) (12)
Determinants of Hospital Mortality Among Patients with Sepsis or Septic Shock Receiving Appropriate Antibiotic Treatment (2013) (12)
Risk factors for mixed complicated skin and skin structure infections to help tailor appropriate empiric therapy. (2012) (12)
DeepAlerts: Deep Learning Based Multi-Horizon Alerts for Clinical Deterioration on Oncology Hospital Wards (2020) (12)
Controversies and advances in the management of ventilator associated pneumonia (2017) (11)
Improving outcomes in the ICU setting: are we effectively using all of the information that is potentially available to us? (1999) (11)
Erratum for Micek et al., “Risk Factors and Outcomes for Ineffective Empiric Treatment of Sepsis Caused by Gram-Negative Pathogens: Stratification by Onset of Infection” (2018) (11)
PROBIOTIC MANIPULATION OF THE NATIVE FLORA IN CRITICALLY ILL PATIENTS: AN OPPORTUNITY FOR VENTILATOR-ASSOCIATED PNEUMONIA PROPHYLAXIS? (2005) (11)
Long-term effects of selective decontamination on antimicrobial resistance. (1996) (11)
Conservative fluid therapy in septic shock: an example of targeted therapeutic minimization (2014) (11)
Novel Approaches to Hasten Detection of Pathogens and Antimicrobial Resistance in the Intensive Care Unit (2019) (11)
Clinical epidemiology of carbapenem‐resistant gram‐negative sepsis among hospitalized patients: Shifting burden of disease? (2018) (10)
Mortality Prediction in ICUs Using A Novel Time-Slicing Cox Regression Method (2015) (10)
Prevention of VAP: the whole is more than the sum of its parts (2008) (10)
COUNTERPOINT: Should Inhaled Antibiotic Therapy Be Used Routinely for the Treatment of Bacterial Lower Respiratory Tract Infections in the ICU Setting? No. (2017) (10)
Update on the appropriate use of meropenem for the treatment of serious bacterial infections. (2008) (10)
Ceftolozane/tazobactam versus meropenem in patients with ventilated hospital-acquired bacterial pneumonia: subset analysis of the ASPECT-NP randomized, controlled phase 3 trial (2021) (10)
Acute respiratory failure: a gender-based outcomes analysis. (1998) (9)
A Pragmatic Machine Learning Model To Predict Carbapenem Resistance (2020) (9)
Ventilator-associated pneumonia: the role of emerging therapies and diagnostics. (2015) (9)
Bench-to-bedside review: Understanding the impact of resistance and virulence factors on methicillin-resistant Staphylococcus aureus infections in the intensive care unit (2009) (9)
Outcomes research in the ICU setting: is it worthwhile? (1997) (9)
Ceftolozane/tazobactam probability of target attainment and outcomes in participants with augmented renal clearance from the randomized phase 3 ASPECT-NP trial (2021) (9)
A Prospective One-Year Microbiologic Survey of Combined Pneumonia and Respiratory Failure. (2017) (9)
Acute pulmonary embolism triggered by the act of defecation. (1991) (9)
Acquired organ system derangements and hospital mortality: are all organ systems created equally? (1999) (9)
Critical Care Aspects of Lung Transplant Patients (2002) (9)
Effects of empiric antifungal therapy for septic shock on time to appropriate therapy for Candida infection: a pilot study. (2014) (9)
CD4+ lymphocyte adenosine triphosphate determination in sepsis: a cohort study (2010) (9)
Pathogen-Negative Sepsis—An Opportunity for Antimicrobial Stewardship (2019) (9)
Will procalcitonin reduce antibiotic use in intensive care? (2010) (9)
COMPARISON OF DEPTH OF SEDATION MEASURED BY PSA 4000 AND RICHMOND AGITATION-SEDATION SCALE (RASS) (2005) (8)
Prevention of pneumonia in the hospital setting. (2005) (8)
Intrinsic PEEP and unilateral lung hyperinflation. Pathophysiology and clinical significance. (1992) (8)
Editorial Commentary: Antimicrobial De-escalation: What's in a Name? (2016) (8)
Silver-Coated Endotracheal Tubes and Patient Outcomes in Ventilator-Associated Pneumonia—Reply (2008) (8)
Fallibility of persistent blood return for confirmation of intravascular catheter placement in patients with hemorrhagic thoracic effusions. (1994) (8)
Randomized Trial Ventilator-Associated Pneumonia: The NASCENT Silver-Coated Endotracheal Tubes and Incidence of (2008) (8)
The Feasibility of Implementing Targeted SEDation in Mechanically Ventilated Emergency Department Patients: The ED-SED Pilot Trial* (2022) (8)
Macrolides are associated with a better survival rate in patients hospitalized with community-acquired but not healthcare-associated pneumonia. (2014) (8)
The intensive care unit as a research laboratory: developing strategies to prevent antimicrobial resistance. (2006) (8)
Symptomatic pleural effusion after coronary artery revascularization: unsuspected pleural injury from internal mammary artery resection. (1993) (8)
Protocol for a multicentre, prospective cohort study of practice patterns and clinical outcomes associated with emergency department sedation for mechanically ventilated patients: the ED-SED Study (2018) (8)
DEVELOPING A NEW, NATIONAL APPROACH (2013) (8)
Developing a new national approach to surveillance for ventilator-associated events: executive summary. (2013) (8)
Feasibility Study of Monitoring Deterioration of Outpatients Using Multimodal Data Collected by Wearables (2020) (8)
Tracheostomy for respiratory failure: we need more answers. (2004) (7)
In 2035, will all bacteria be multiresistant? Yes (2016) (7)
PROPHETIC: Prospective Identification of Pneumonia in Hospitalized Patients in the Intensive Care Unit. (2020) (7)
Scheduled change of antibiotic classes (1998) (7)
Nonpharmacological prevention of hospital-acquired pneumonia. (2002) (7)
Reduced Mortality in Patients Intubated with a Silver-Coated Endotracheal Tube in Those Who Developed Ventilator-Associated Pneumonia in the NASCENT Randomized Study. (2009) (7)
ICD-9-CM Coding for Multidrug Resistant Infection Correlates Poorly With Microbiologically Confirmed Multidrug Resistant Infection (2017) (7)
A study protocol for a multicentre, prospective, before-and-after trial evaluating the feasibility of implementing targeted SEDation after initiation of mechanical ventilation in the emergency department (The ED-SED Pilot Trial) (2020) (7)
Healthcare-associated pneumonia: approach to management. (2011) (7)
Pleural effusion in patients with systemic cholesterol embolization. (1993) (7)
Antibiotic Thresholds for Sepsis and Septic Shock. (2018) (7)
Patients hospitalized with pneumonia: determining the need for broad-spectrum antibiotic therapy. (2012) (7)
Ventilator-associated pneumonia prevention: we still have a long way to go! (2014) (7)
Partial pressure of arterial carbon dioxide and survival to hospital discharge among patients requiring acute mechanical ventilation: A cohort study (2017) (7)
Methicillin-resistant Staphylococcus aureus (MRSA) nasal colonization predicts intensive care unit-acquired MRSA infections: true or false? (2010) (7)
Why is Acinetobacter baumannii a problem for critically ill patients? (2015) (7)
“Does this patient have…” “Is this patient at risk for infection with multidrug resistant bacteria?” (2017) (7)
Determinants of Outcome for Patients Admitted to a Long-Term Ventilator Unit (2002) (7)
Evaluation of a ceiling effect on the association of new resistance development to antipseudomonal beta-lactam exposure in the critically ill (2020) (7)
Protocol for a prospective, observational cohort study of awareness in mechanically ventilated patients admitted from the emergency department: the ED-AWARENESS study (2019) (7)
Augmented renal clearance is not a risk factor for mortality in Enterobacteriaceae bloodstream infections treated with appropriate empiric antimicrobials (2017) (7)
Healthcare-associated pneumonia. (2009) (6)
Management of Infections with Drug-Resistant Organisms in Critical Care: An Ongoing Battle. (2015) (6)
To which extent can we decrease antibiotic duration in critically ill patients? (2017) (6)
Defecation syncope caused by pulmonary embolism. (1990) (6)
Ventilator-associated pneumonia and ventilator-induced lung injury: two peas in a pod. (2002) (6)
The importance of antimicrobial resistance in hospital-acquired and ventilator-associated pneumonia (2005) (6)
Comparison of Venography, Duplex Imaging, and Bilateral Impedance Plethysmography for Diagnosis of Lower Extremity Deep Vein Thrombosis (1994) (6)
Elaboration of Consensus Clinical Endpoints to Evaluate Antimicrobial Treatment E cacy in Future Hospital- acquired/Ventilator-associated Bacterial Pneumonia Clinical Trials (2019) (6)
Prevention of Staphylococcus aureus Ventilator-Associated Pneumonia: Conventional Antibiotics Won't Cut It. (2017) (6)
Outcomes of Macrolide Deescalation in Severe Community-Acquired Pneumonia. (2019) (6)
Non-invasive ventilation for chronic obstructive pulmonary disease (2000) (6)
Evaluating the Value of the Respiratory Therapist: Where Is the Evidence? Focus on the Barnes-Jewish Hospital Experience (2017) (6)
What's new about ventilator-associated pneumonia. (2001) (6)
A Noteworthy Case of Acute Bronchitis. (2016) (6)
CAP, HCAP, HAP, VAP: The Diachronic Linguistics of Pneumonia. (2017) (6)
Ventilator-associated tracheobronchitis and ventilator-associated pneumonia: truth vs myth. (2013) (6)
Culturing bronchial washings obtained during bronchoscopy fails to add diagnostic utility to culturing the bronchoalveolar lavage fluid alone. (2002) (6)
Postpartum pulmonary infiltrates with peripheral eosinophilia. (1991) (6)
Assessment of Antibiotic De-escalation by Spectrum Score in Patients With Nosocomial Pneumonia: A Single-Center, Retrospective Cohort Study (2021) (6)
Linezolid and Vancomycin for Methicillin-Resistant Staphylococcus aureus Nosocomial Pneumonia (2004) (6)
Postoperative Pneumonia Prevention in Pulmonary Resections: A Feasibility Pilot Study. (2019) (6)
The threat of multidrug-resistant/extensively drug-resistant Gram-negative respiratory infections: another pandemic (2022) (5)
We should listen to the patient when it comes to timing extubation. (1998) (5)
Clinical practice improvement initiatives: don't be satisfied with the early results. (2009) (5)
1233A Comparison of National Healthcare Safety Network (NHSN) Ventilator Associated Pneumonia (VAP) and Ventilator Associated Event (VAE) Definitions (2014) (5)
The Relationship of the ACCP/SCCM Consensus Conference Classification of Sepsis to Mortality and Multiorgan Dysfunction among Medical ICU Patients (1996) (5)
Using Protocols To Improve the Outcomes of Critically Ill Patients with Infection: Focus on Ventilator-Associated Pneumonia and Severe Sepsis (2007) (5)
The Impact of Nighttime Intensivists on Medical Intensive Care Unit Infection-Related Indicators (2015) (5)
New Perspectives on Antimicrobial Agents: Ceftolozane-Tazobactam (2021) (5)
GROWTH IN THE INCIDENCE OF HOSPITALIZATIONS WITH RESISTANT INFECTIONS IN ELDERLY PEOPLE IN THE UNITED STATES: 2000 TO 2006 (2008) (5)
Critical Care Infectious Diseases Textbook (2001) (5)
How I diagnose and manage ventilator-associated tracheobronchitis. (2016) (5)
Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial (2022) (5)
Outcomes research as a tool for defining the role of respiratory care practitioners in the intensive care unit setting. (1998) (5)
Infection control in the intensive care unit: expert consensus statements for SARS-CoV-2 using a Delphi method (2021) (5)
Timing of Appropriate Antibiotics in Sepsis: How Much Does Each Hour Matter? (2016) (5)
Awareness With Paralysis Among Critically Ill Emergency Department Patients: A Prospective Cohort Study* (2022) (5)
The effect of an increased index of suspicion on the diagnosis of pneumothorax in the critically ill. (1992) (5)
New antimicrobial treatment options for severe Gram-negative infections (2022) (4)
Preventive strategies in VAP: Focus on silver-coated endotracheal tubes (2013) (4)
Telavancin for Hospital-Acquired Pneumonia: Clinical Response and 28-Day Survival (2014) (4)
Recurrent unilateral lung hyperinflation as a manifestation of "auto-PEEP". (1993) (4)
Characteristics of U.S. Acute Care Hospitals That Have Implemented Telemedicine Critical Care (2021) (4)
Outcomes research at the end of life. (2000) (4)
Experiences with an end-to-end wireless clinical monitoring system (2012) (4)
Vancomycin/Pipiercillin-Tazobactam Nephrotoxicity in the Critically Ill. (2019) (4)
Comparison of early warning scores for sepsis early identification and prediction in the general ward setting (2021) (4)
Probiotics for ventilator-associated pneumonia: the need for a large, multicenter, randomized controlled trial. (2013) (4)
Low Tidal Volume Ventilation for Emergency Department Patients: A Systematic Review and Meta-Analysis on Practice Patterns and Clinical Impact* (2022) (4)
Racial Disparities in Readmissions Following Initial Hospitalization for Sepsis (2021) (4)
POINT: Does Persistent or Worsening ARDS Refractory to Optimized Ventilation and Proning Deserve a Trial of Prostacyclin? Yes. (2019) (4)
718Predictors of Hospital Mortality Among Septic ICU Patients With Acinetobacter spp. Bacteremia: A Cohort Study (2014) (4)
A Comparison of Culture-Negative and Culture-Positive Health Care-Associated Pneumonia. (2009) (4)
The most recent concepts for the management of bacterial and fungal infections in ICU (2018) (4)
β-Lactam Therapeutic Drug Monitoring in Critically Ill Patients: Weighing the Challenges and Opportunities to Assess Clinical Value (2022) (4)
Loculated hemopneumothorax of a major fissure in patients with COPD and associated pleural disease. (1990) (4)
Prevention of Postoperative Pneumonia (2007) (4)
Soluble triggering receptor expressed on myeloid cells 1 and the diagnosis of ventilator-associated pneumonia. (2009) (4)
Health-care-associated pneumonia: not just a US phenomenon. (2009) (4)
TELAVANCIN: A NOVEL AGENT FOR VENTILATOR-ASSOCIATED PNEUMONIA DUE TO STAPHYLOCOCCUS AUREUS (2008) (3)
Integrating Static and Time-Series Data in Deep Recurrent Models for Oncology Early Warning Systems (2021) (3)
A Dual-Center Cohort Study on The Association Between Early Deep Sedation and Clinical Outcomes in Mechanically Ventilated Patients During the COVID-19 Pandemic: the COVID-SED Study (2022) (3)
Prospective Nasal Screening for Methicillin-Resistant Staphylococcus aureus in Critically Ill Patients With Suspected Pneumonia (2021) (3)
Reduction in antimicrobial use among medical intensive care unit patients during a cluster randomized crossover trial of palliative care consultation (2019) (3)
Healthcare Resource Utilization of Ceftolozane/Tazobactam Versus Meropenem for Ventilated Nosocomial Pneumonia from the Randomized, Controlled, Double-Blind ASPECT-NP Trial (2020) (3)
A targeted educational intervention to reduce ventilator-associated complications. (2016) (3)
Should we be debating the importance of timely adequate antimicrobial therapy? (2010) (3)
Use of a Shared Canister Protocol for the Delivery of Metered-Dose Inhalers in Mechanically Ventilated Subjects (2016) (3)
Characteristics and outcomes among a hospitalized patient cohort with Streptococcus pneumoniae infection (2020) (3)
Rescue therapy for the acute respiratory distress syndrome (ARDS) (1997) (3)
640: DURATION OF BROAD-SPECTRUM ANTIMICROBIALS IN THE CRITICALLY ILL AND DEVELOPMENT OF NEW RESISTANCE (2016) (3)
Outcomes Of Vancomycin Weight Based Dosing By Trough Concentrations For The Treatment Of Hospital Acquired Pneumonia Caused By Methicillin-Resistant Staphylococcus Aureus (2011) (3)
The role of outcomes research in the intensive care unit setting. (1998) (3)
Candidemia and non-candidemia related septic shock: are there differences between them? (2014) (3)
Pacing wire-induced recurrent ventricular tachycardia secondary to kinetic therapy bed motion. (1988) (3)
Antibiotic heterogeneity: should we use it? (2003) (3)
Principles of antimicrobial stewardship for bacterial and fungal infections in ICU (2017) (3)
The Effect of an Education Program on the Incidence of Catheter-Associated Bloodstream Infection in a Medical Intensive Care Unit (2004) (3)
Improving the appropriateness and effectiveness of ICU practices (1998) (3)
Real-time automated clinical deterioration alerts predict thirty-day hospital readmission. (2016) (3)
The road forward in the management of Acinetobacter infections in the ICU (2015) (3)
Treatment of hospital-acquired pneumonia. (1997) (3)
Pneumococal community-acquired pneumonia in the intensive care unit: Azithromycin remains protective despite macrolide resistance. (2021) (2)
Open access to infectious disease case-based learning on the Internet. (2008) (2)
Linezolid Vs. Vancomycin For Ventilator-Associated Pneumonia Caused By Methicillin-Resistant Staphylococcus Aureus (2011) (2)
Recognition of Nosocomial Pneumonia in the Intensive Care Unit: Still a Confusing Issue (2011) (2)
Five Versus Seven Day Antibiotic Course For The Treatment Of Pneumonia In The Intensive Care Unit (2012) (2)
ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia (2023) (2)
Utility of transbronchial biopsy in patients with acute respiratory failure (1999) (2)
Thirty-day hospital readmissions among mechanically ventilated emergency department patients (2018) (2)
Recommendations for aerosolized antibiotics in ventilator-associated pneumonia and ventilator-associated tracheobronchitis: too little and too late? (2017) (2)
Escalation/De-escalation of Initial Empiric Ventilator-Associated Pneumonia Therapy: Interim Results from the Assessment of Local Antimicrobial Resistance Measures Study (2004) (2)
Bugging the bugs: novel approaches in the strategic management of resistant Staphylococcus aureus infections. (2007) (2)
Validation Of A Clinical Score For Assessing The Risk Of Resistant Pathogens In Pneumonia Presenting To The Emergency Department (2012) (2)
Bloodstream Infections and Delayed Antibiotic Coverage are Associated with Negative Hospital Outcomes in Hematopoietic Stem Cell Transplant Recipients. (2020) (2)
Institutional perspective on the impact of positive blood cultures on the economic and clinical outcomes of patients with complicated skin and skin structure infections: focus on gram-positive infections. (2011) (2)
New approaches to the diagnosis of VAP (1997) (2)
Race Does Not Impact Sepsis Outcomes When Considering Socioeconomic Factors in Multilevel Modeling (2021) (2)
Systematic Use of a Silver-Coated Endotracheal Tube Reduces Ventilator-Associated Pneumonia Rates (2009) (2)
What is new in infection prevention in critical care in 2014? (2014) (2)
Therapist-directed protocols: Their time has come (1999) (2)
Impact of baseline characteristics on future episodes of bloodstream infections: Multistate model in septic patients with bloodstream infections. (2019) (2)
Adult respiratory distress syndrome after smoke inhalation from burning poison ivy. (1995) (2)
Silver-coated endotracheal tubes: Is the bactericidal effect time limited? (2007) (2)
If antibiotics did not exist (2015) (2)
Update on Clostridium difficile Hospitalizations in the US Through 2008: The Epidemic Continues (2011) (2)
Diagnosis and Treatment of Acute Respiratory Distress Syndrome. (2018) (2)
Inhaled nitric oxide for severe acute respiratory distress syndrome: a blessing or a curse? (1997) (2)
Transfusion: A Risk Factor for Nosocomial Bacteremia in the Intensive Care Unit (2004) (2)
Pulmonary embolism masquerading as pulmonary arteriovenous malformation on computerized tomography. (1989) (2)
Early Palliative Care Consultation in the Medical Intensive Care Unit—A Clustered Randomized Crossover Trial (TH371B) (2019) (2)
Hospital-Acquired Pneumonia (1989) (2)
The Resuscitation Package in Sepsis (2010) (2)
Monoclonal antibodies as antibacterial therapies: thinking outside of the box. (2021) (2)
Doripenem for treating nosocomial pneumonia and ventilator-associated pneumonia - Authors' reply. (2020) (2)
Limitations of Registration Trials for Nosocomial Pneumonia. (2020) (2)
Vancomycin for methicillin-resistant Staphylococcus aureus pneumonia: the good, the bad, and the ugly. (2012) (2)
Clinical Impact of Expedited Pathogen Identification and Susceptibility Testing for Gram-negative Bacteremia and Candidemia Using the Accelerate Pheno™ System (2017) (2)
Hemothorax and an abdominal hematoma after treatment of ischemic cardiomyopathy with warfarin. (1994) (2)
The Importance of Initial Empiric Antibiotic Selection in Ventilator-Associated Pneumonia (1998) (2)
Ventilator-Associated Events: Are We Missing the Forest for the Trees? (2015) (2)
MORBIDITY OF VENTILATOR-ASSOCIATED PNEUMONIA IN A RANDOMIZED STUDY OF A SILVER-COATED ENDOTRACHEAL TUBE (2007) (2)
Differences in mortality between infections due to extended-spectrum-beta-lactamase–producing Klebsiella pneumoniae and Escherichia coli (2018) (1)
Preface. Infections in the intensive care unit. (2009) (1)
Erratum for Drusano et al., “Dilution Factor of Quantitative Bacterial Cultures Obtained by Bronchoalveolar Lavage in Patients with Ventilator-Associated Bacterial Pneumonia” (2018) (1)
1483: MONOCYTE FUNCTION AND CLINICAL OUTCOMES IN FEBRILE AND AFEBRILE PATIENTS WITH SEVERE SEPSIS (2018) (1)
Is Prevention of Ventilator- Associated Pneumonia Cost Effective? (2001) (1)
166Rapid MRSA PCR on Respiratory Specimens from Ventilated Patients with Suspected Pneumonia: A Potential Tool for Antimicrobial Stewardship (2014) (1)
How to use new antibiotics in the therapy of ventilator-associated pneumonia (2021) (1)
EFFICAY OF DORIPENEM IN NOSOCOMIAL PNEUMONIA: NON-VENTILATOR-ASSOCIATED AND VENTILATOR-ASSOCIATED PNEUMONIA (2007) (1)
858: HEIGHT ACCURACY IN CRITICALLY ILL PATIENTS (2014) (1)
367: PROSPECTIVE MULTINATIONAL OBSERVATIONAL STUDY OF THE INCIDENCE OF VENTILATOR ASSOCIATED PNEUMONIA (2013) (1)
Short-Term Effects of Appropriate Empirical Antimicrobial Treatment with Ceftolozane/Tazobactam in a Swine Model of Nosocomial Pneumonia (2020) (1)
Predictors of lung infection among hospitalized patients undergoing bronchoalveolar lavage (1997) (1)
Inadequate antibiotic treatment of microbiologically proven infection is an independent determinant of hospital mortality for patients requiring intensive care (1998) (1)
A Phase 3, Double-Blind, Double-Dummy Study Assessing The Safety And Efficacy Of A Short Course Of Doripenem 1 Gram In The Treatment Of Subjects With Ventilator-Associated Pneumonia (2012) (1)
282: THE IMPACT OF EARLY DEEP SEDATION IN MECHANICALLY VENTILATED PATIENTS DURING THE COVID-19 PANDEMIC (2021) (1)
THE ROLE OF ANTIBIOTICS IN THE MANAGEMENT OF SERIOUS HOSPITAL-ACQUIRED INFECTIONS (2008) (1)
Moving the Practice of Respiratory Therapy Forward (2019) (1)
Rebuttal From Dr Kollef. (2017) (1)
Outcomes in participants with failure of initial antibacterial therapy for hospital-acquired/ventilator-associated bacterial pneumonia prior to enrollment in the randomized, controlled phase 3 ASPECT-NP trial of ceftolozane/tazobactam versus meropenem (2022) (1)
Impact of Stress Ulcer Prophylaxis Discontinuation Guidance in Mechanically Ventilated, Critically Ill Patients: A Pre-Post Cohort Study (2021) (1)
Ventilator Circuit Changes (1996) (1)
Outcomes of In-Hospital Cardiac Arrest Among Hospitals With and Without Telemedicine Critical Care. (2022) (1)
A magic bullet for sepsis: getting back to the basics. (2010) (1)
Predicting Clinical Deterioration of Outpatients Using Multimodal Data Collected by Wearables (2018) (1)
The Practice Change and Clinical Impact of Lung-Protective Ventilation Initiated in the Emergency Department: A Secondary Analysis of Individual Patient-Level Data From Prior Clinical Trials and Cohort Studies* (2022) (1)
IMPLEMENTATION OF AN EARLY GOAL-DIRECTED SEPSIS PROTOCOL IN AN ACADEMIC EMERGENCY DEPARTMENT.: 195-T (2005) (1)
A Patient Referred for Steroid-Resistant Asthma* (1990) (1)
339An International, Multicenter, Retrospective Study of Nosocomial Pneumonia due to Pseudomonas aeruginosa (2014) (1)
Reversible hypotension following pulmonary embolism in a 33-year-old woman with hypothyroidism and vitiligo. (1993) (1)
Reply to Moine and Bédos (2005) (1)
Aerolized antibiotics for the treatment of Ventilator Associated Pneumonia: A new era! (2014) (1)
Occult coiled drinking straw aspiration. (1990) (1)
Prevention of Antibiotic Resistance in Hospitals (2002) (1)
VAP prevention: pharmacological strategies (2011) (1)
Predictors Of Clinical Failure And Mortality Among Patients With Methicillin Resistant Staphylococcus Aureus (MRSA) Hospital-Acquired Pneumonia (2011) (1)
Why Appropriate Antimicrobial Selection is Important: Focus on Outcomes (2004) (1)
Early Appropriate Empiric Therapy and Antimicrobial De-Escalation (2007) (1)
The AIR-SED Study: A Multicenter Cohort Study of SEDation Practices, Deep Sedation, and Coma Among Mechanically Ventilated AIR Transport Patients (2021) (1)
51: EMERGENCY DEPARTMENT LUNG-PROTECTIVE VENTILATION REDUCES PULMONARY COMPLICATIONS: THE LOV-ED TRIAL (2016) (1)
An Outcomes‐Based Approach to Ventilatory Management: Review of Two Examples (1999) (1)
HEALTHCARE-ASSOCIATED PNEUMONIA: A VALUABLE CONCEPT AT PREDICTING RESISTANT INFECTION? (2008) (1)
Appropriate Pharmacokinetic Index for Outcome in Staphylococcus aureus Pneumonia (2007) (1)
Incidence of Clostridium Difficile Infection in the Intensive Care Setting: Results of a Multicenter Study (2012) (1)
Reply to Taccone et al, Wolff and Mourvillier, Masuta and Iwata, and Lahey (2012) (1)
Prevention and treatment of methicillin-resistant Staphylococcus aureus colonization in the ICU: a process of care that should be considered mandatory. (2014) (1)
Corticosteroids for Influenza Pneumonia: Hold Off for Now! (2016) (1)
Non-Pharmacologic Prevention of Ventilator-Associated Pneumonia (VAP) (2000) (1)
Predicting intensive care unit outcome: Preface (1994) (1)
43. PREVENTION OF VENTILATOR ASSOCIATED PNEUMONIA (2001) (1)
Sepsis Prediction for the General Ward Setting (2022) (1)
Roentgenogram of the month. A patient referred for steroid-resistant asthma. (1990) (1)
NoNiNvasive MeasureMeNt of CardiaC output for early reCogNitioN of septiC shoCk aNd tar- geted therapy (2013) (0)
CONTINUOUS IV SEDATION AND PROLONGED MECHANICAL VENTILATION. AUTHOR'S REPLY (1999) (0)
Effects of Overnight Attending Intensivist Coverage in Medical Intensive Care Units on Infection-Related Indicators (2015) (0)
Minibronchoalveolar Lavage by Respiratory Therapists (1996) (0)
The influence of gender on outcome from mechanical ventilation (1996) (0)
Pulmonary embolism associated with postoperative deep breathing. (1992) (0)
Chapter 83 Antibiotics in the Management of Serious Hospital-Acquired Infections (2017) (0)
PSEUDOMONAS AERUGINOSA BACTEREMIA: THE IMPORTANCE OF ADEQUATE INITIAL ANTIMICROBIAL TREATMENT: 528 (2004) (0)
A Machine Learning Approach to Sepsis Prediction in non-Intensive Care Unit Patients (2019) (0)
The Predictive Value Of MRSA Screening For Subsequent Infection In The ICU Setting (2010) (0)
Analytical Performance Characteristics of the Accelerate Pheno™ System for Pathogen Identification and Susceptibility Testing for Gram-negative Bacteremia and Candidemia (2017) (0)
Quinolones For Nosocomial Pneumonia: A Meta-analysis (2004) (0)
Outcome in Medical Intensive Care Unit Patients Requiring Abdominal Surgery: Prospective Validation of a Risk Classification System (1997) (0)
Clinician Perspectives on Barriers and Enablers to Implementing an Inpatient Oncology Early Warning System: A Mixed-Methods Study. (2023) (0)
SELECTIVE CLEANING PROCEDURE TO REDUCE THE ACQUISITION OF CLOSTRIDIUM DIFFICILE IN A MEDICAL INTENSIVE CARE UNIT: 340 (2004) (0)
The Burden of Methicillin Resistant Staphylococcus aureus in Ventilator-Associated Pneumonia (2004) (0)
Toxin Inhibition And Gram-Positive Infection: Focus on Methicillin-Resistant Staphylococcus aureus Expressing the Panton-Valentine Leukocidin Gene (2006) (0)
BIOMARKER FOR STAGING THE HOST IMMUNE RESPONSE IN SEPSIS (2008) (0)
Mechanical Ventilation: Protocol-Driven Strategies (2001) (0)
Antimicrobial stewardship for sepsis in the intensive care unit: Survey of critical care and infectious diseases physicians (2022) (0)
Rapid MRSA PCR on respiratory specimens from ventilated patients with suspected pneumonia: a tool to facilitate antimicrobial stewardship (2016) (0)
Mechanical Ventilation Practices and Low Tidal Volume Ventilation in Air Medical Transport Patients: The AIR-VENT Study (2022) (0)
540: Pressure Ulcer Incidence with Patients Wearing Nasal/Oral Compared to Full Face NIV Masks (2013) (0)
The authors reply. (2018) (0)
PREDICTORS OF DEATH AMONG PATIENTS WITH VENTILATOR-ASSOCIATED PNEUMONIA: AN ANALYSIS OF THE ASSESSMENT OF LOCAL ANTIMICROBIAL RESISTANCE MEASURES (ALARM) STUDY DATA (2005) (0)
EFFECTS OF BOLUS VERSUS CONTINUOUS TUBE FEEDINGS ON GLYCEMIC CONTROL IN MEDICAL INTENSIVE CARE UNIT PATIENTS.: 171-M (2005) (0)
CONSERVATIVE, LIBERAL, OR BOTH? AN ANALYSIS OF FLUID MANAGEMENT IN ACUTE LUNG INJURY SECONDARY TO SEPTIC SHOCK (2008) (0)
Reply to MacFadden et al. (2018) (0)
1020: Identifying patients at risk for inappropriate antibiotic therapy using a point-of-care alert (2013) (0)
Combination of aspirin plus macrolides in patients with severe community-acquired pneumonia: a hypothesis-generating study (2018) (0)
The authors reply. (2016) (0)
Essentials of Mechanical Ventilation (1996) (0)
1130: MECHANICAL VENTILATION PRACTICES AMONG AIR MEDICAL TRANSPORT PATIENTS: A COHORT STUDY (2021) (0)
High levels of C-reactive protein and positive troponin T test results predicted 14-day mortality in unstable angina or non-Q-wave MI (1998) (0)
Redefining the Threshold for Broad-Spectrum Antibiotics. (2019) (0)
LINEZOLID VS VANCOMYCIN: PREDICTORS OF SURVIVAL IN PATIENTS WITH VENTILATOR-ASSOCIATED PNEUMONIA: 412 (2002) (0)
Prevention of antibiotic resistance in hospitals. Author's reply (2002) (0)
1013: AN ED VENTILATOR PROTOCOL INCREASES LUNG PROTECTION FOR PATIENTS AT RISK OF COMPLICATIONS (2016) (0)
VENTILATOR-ASSOCIATED TRACHEOBRONCHITIS IN A MIXED SURGICAL AND MEDICAL INTENSIVE CARE UNIT POPULATION (2009) (0)
Respiratory support status from EHR data for adult population: classification, heuristics, and usage in predictive modeling (2022) (0)
Invasive Diagnostic Approaches to Ventilator-Associated Pneumonia: A Metaanalysis (2004) (0)
PROSPECTIVE MULTINATIONAL OBSERVATIONAL STUDY OF THE INCIDENCE OF VENTILATOR ASSOCIATED PNEUMONIA (2013) (0)
What does it mean: Appropriate therapy for methicillin-resistant Staphylococcus aureus? (2007) (0)
BACTEREMIA MODIFIES THE EFFECT OF INITIAL ANTIBIOTIC TREATMENT ON HOSPITAL MORTALITY DIFFERENTIALLY IN CAP AND HCAP (2008) (0)
Protocol for DRAUP: a deimplementation programme to decrease routine chest radiographs after central venous catheter insertion (2021) (0)
Communications to the EditorTo the Editor (2005) (0)
Adult respiratory distress syndrome: learning lessons from the past. (1996) (0)
Results ofa Randomized Clinical Trial (2017) (0)
249: PRINCIPAL COMPONENT ANALYSIS IDENTIFIES DISCRETE PATTERNS OF HOSPITAL CAPABILITIES RELATED TO SEPSIS (2022) (0)
Ceftriaxone resistance and adequacy of initial antibiotic therapy in community onset bacterial pneumonia (2022) (0)
Is Dead Space a New Marker for Gravity on Pediatric Acute Hypoxemic Respiratory Failure? (2015) (0)
245: Predictors of Central Venous Cannulation Complications in the Emergency Department (2008) (0)
HAP, VAP, AND HCAP PATIENTS IN THE APEKS-NP CLINICAL TRIAL HAD SIMILAR GRAM-NEGATIVE MICROBIOLOGY: MORTALITY WAS DRIVEN BY VENTILATION STATUS (2021) (0)
2521 Use of forced air warming devices to induce fever-range hyperthermia in critically ill septic patients (2018) (0)
34: EARLY PALLIATIVE CARE CONSULTATION IN THE MEDICAL ICU A CLUSTER RANDOMIZED CROSSOVER TRIAL (2019) (0)
1894. Antimicrobial Stewardship in the Intensive Care Unit: Survey of Critical Care and Infectious Diseases Physicians (2018) (0)
Short- Versus Standard-Course Nonmacrolide Antibiotic Treatment in Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Retrospective, Observational Cohort Study. (2021) (0)
EFFECTS OF VASOPRESSIN PLUS NOREPINEPHRINE COMPARED TO NOREPINEPHINE ON THE OUTCOME OF SEPTIC SHOCK: 534 (2004) (0)
Life-Threatening Infections: Pulmonary and Systemic Infections. (2022) (0)
Levofloxacin for Ventilator-Associated PneumoniaFREE TO VIEW (2003) (0)
690: DISCONTINUATION OF MICAFUNGIN THERAPY UTILIZING A VALIDATED CLINICAL PREDICATION RULE FOR CANDIDEMIA (2016) (0)
Prophetic EU: Prospective Identification of Pneumonia in Hospitalized Patients in the Intensive Care Unit–A Comparison of European and United States Cohorts (2021) (0)
The effect of partial upper-airway bypass on subglottic pressure during acute lung injury in sheep (1992) (0)
Issue Information ‐ Table of Content (2022) (0)
Outcomes in participants with ventilated nosocomial pneumonia and organ failure treated with ceftolozane/tazobactam versus meropenem: a subset analysis of the phase 3, randomized, controlled ASPECT-NP trial (2023) (0)
Ocular Manifestations of Pediatric Pulmonary Diseases (2017) (0)
693: INCIDENCE OF CLOSTRIDIUM DIFFICILE INFECTION IN THE INTENSIVE CARE SETTING (2012) (0)
The importance of viruses in ventilator-associated pneumonia. (2022) (0)
Next steps in pneumonia severity scores. (2020) (0)
Principles and Practice of Medical Intensive Care (1995) (0)
An Outcomes-Based Approach to Ventilatory Management: Review of Two Examples (1999) (0)
Validation of a risk classification (BLEED), used in the emergency room, to predict outcomes for upper and lower gastrointestinal bleeding (1996) (0)
1106: LOW TIDAL VOLUME VENTILATION FOR EMERGENCY DEPARTMENT PATIENTS: SYSTEMATIC REVIEW AND META-ANALYSIS (2021) (0)
Hospital-acquired pneumonia/ventilator-associated pneumonia prevention: truth or dare! (2011) (0)
Prevention of nosocomial respiratory infections (2006) (0)
413: COST ANALYSIS OF EMPIRIC COVERAGE FOR PATIENTS WITH MDR GRAM-NEGATIVE INFECTIONS (2022) (0)
Medical trainee experience versus optimizing clinical outcomes: achieving the best of both. (2000) (0)
Assessment of risk factors for inappropriate empiric antibiotic therapy in patients with Gram-negative sterile site infection complicated by sepsis or septic shock (2017) (0)
Lack of pathogen identification influencing antibiotic de-escalation in hospital-acquired pneumonia (2022) (0)
Pathogens in Severe Sepsis: New Paradigms for Gram-Positive Treatment (2012) (0)
Vancomycin administration in cardiac surgical patients. (1994) (0)
Comprar Infections in the Intensive Care Unit, An Issue of Infectious Disease Clinics | Marin H. Kollef MD | 9781437712315 | Saunders (2009) (0)
940: THE IMPACT OF AN ED VENTILATOR PROTOCOL ON ADHERENCE TO LUNG-PROTECTIVE VENTILATION IN ARDS (2016) (0)
616: OUTCOMES IN PATIENTS WITH AUGMENTED RENAL CLEARANCE TREATED WITH CEFTOLOZANE-TAZOBACTAM IN ASPECT-NP (2020) (0)
872. PROPHETIC: Predicting Pneumonia in Hospitalized Patients in the ICU—A Model and Scoring System (2018) (0)
Silver-CoatedEndotrachealTubesandIncidence of Ventilator-Associated Pneumonia (2017) (0)
MINIBRONCHOALVEOLAR LAVAGE BY RESPIRATORY THERAPISTS. AUTHOR'S REPLY (1996) (0)
INAPPROPRIATE ANTIFUNGAL THERAPY FOR CANDIDEMIA AND HOSPITAL RESOURCE UTILIZATION (2009) (0)
231. Outcomes by Baseline Pathogen and Susceptibility in the ReSTORE Phase 3 Trial of Rezafungin Once Weekly Compared with Caspofungin Once Daily in Patients with Candidemia and/or Invasive Candidiasis (2022) (0)
VENTILATOR CIRCUIT CHANGES. AUTHORS' REPLY (1996) (0)
Preventing bacterial resistance : Antibiotic cycling and alternative stratégies (2006) (0)
Comparison of Deep Learning, Machine Learning, and Penalized Logistic Regression for Predicting Clinical Deterioration in Oncology Inpatients (2020) (0)
HEALTHCARE-ASSOCIATED PNEUMONIA: THE STATE OF EVIDENCE TO DATE?A QUALITATIVE REVIEW (2009) (0)
The authors reply. (2020) (0)
Sepsis from the Critical Care Perspective (2018) (0)
Antibiotic therapy of healthcare-associated pneumonia (2011) (0)
1050: ASPIRIN PLUS MACROLIDE THERAPY IN PATIENTS WITH SEVERE PNEUMONIA A MULTICENTER RETROSPECTIVE STUDY (2018) (0)
732: AZITHROMYCIN AND PNEUMONIA (2012) (0)
Comment: Does Early Vasopressin in Septic Shock Improve Outcomes? An Important Piece to This Emerging Puzzle Has Arrived. (2023) (0)
Participant- and Disease-Related Factors as Independent Predictors of Treatment Outcomes in the RESTORE-IMI 2 Clinical Trial: A Multivariable Regression Analysis (2023) (0)
20: EMERGENCY DEPARTMENT HYPEROXIA AND INCREASED MORTALITY IN MECHANICALLY VENTILATED PATIENTS (2018) (0)
536: Characteristics of US Acute Care Hospitals That Have Implemented Intensive Care Unit Telemedicine (2020) (0)
Comprar The Washington Manual of Critical Care, 2/e | Marin Kollef | 9781451110227 | Lippincott Williams & Wilkins (2011) (0)
Effect of Empirical Treatment With Moxifloxacin andMeropenemvsMeropenemonSepsis-Related (2012) (0)
UNDERSTANDING THE HEALTH CARE-ASSOCIATED PNEUMONIA (HCAP) DEFINITION (2008) (0)
Bacteremia in the setting of MRSA hospital-onset pneumonia is associated with a dramatic increase in the hospital length of stay: a retrospective cohort study (2015) (0)
ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia (2023) (0)
The Flood and Ebb of Septic Shock. Author's reply (2009) (0)
CLINICAL AND TREATMENT PATTERNS AMONG 398 PATIENTS WITH VENTILATOR-ASSOCIATED PNEUMONIA: FINAL RESULTS OF THE ASSESSMENT OF LOCAL ANTIMICROBIAL RESISTANCE MEASURES (ALARM) STUDY (2005) (0)
22: Outcomes of a Chest Radiograph De-Implementation Program: An Implementation Effectiveness Study (2020) (0)
881New Ventilator Associated Event (VAE) Definition: Persistence of Subjective Variability (2014) (0)
CONCOMITANT OPPORTUNISTIC INFECTIONS IN A PATIENT RECEIVING INTRAVENOUS INFLIXIMAB (2008) (0)
Research articleInappropriate empiric antifungal therapy for candidemia in the ICU and hospital resource utilization : a retrospective cohort study (2016) (0)
Microbiologic Failure Despite Clinical Cure in Pneumonia: Cum Hoc and Post Hoc Ergo Propter Hoc. (2019) (0)
How to use new antibiotics in the therapy of serious multidrug resistant Gram-negative infections? (2022) (0)
Relevance of Subpleural Consolidations in Chest Ultrasound (2017) (0)
Study Protocol for Draup: De-implementation Ofroutine Chest Radiographs After Adoption of Ultrasound Guided Insertion and Confirmation of Central Venous Catheter Protocol, A Hybrid Implementation/effectiveness Study (2020) (0)
An International Comparative Study of ICU Management of Pain, Agitation, Delirium and Sedation (2020) (0)
2226. Impact of Prior and Concomitant Antibacterial Therapy on Outcomes in the ASPECT-NP Randomized, Controlled Trial of Ceftolozane/Tazobactam (C/T) vs. Meropenem (MEM) in Patients with Ventilated Nosocomial Pneumonia (NP) (2019) (0)
Augmenting a Clinical Deterioration Alert with a Manual Clinical Assessment of Illness Severity (2013) (0)
articleInappropriate empiric antifungal therapy for candidemia in the ICU and hospital resource utilization : a retrospective cohort study (2010) (0)
Pneumonia in the Hospital Setting (2005) (0)
PROPHETIC EU: Prospective Identification of Pneumonia in Hospitalized Patients in the Intensive Care Unit in European and United States Cohorts (2022) (0)
Association of the metabolic syndrome with age-related , nonatherosclerotic , chronic medical conditions (2016) (0)
ECONOMIC IMPLICATIONS OF SEPSIS PROTOCOL: CAN WE IMPROVE OUTCOMES AND SAVE COSTS?: 73 (2006) (0)
Use of transtracheal catheter for treatment of hypoxic respiratory failure when mechanical ventilation was refused. (1990) (0)
Nasal Airflow in Sleep-Disordered Breathing (2015) (0)
Chapter 23. Staphylococcal Pneumonia (2009) (0)
1097B: A NOVEL HOSPITAL CAPABILITY MEASURE OUTPERFORMS CASE VOLUME IN EXPLAINING SEPSIS MORTALITY (2022) (0)
A dual-center cohort study on the association between early deep sedation and clinical outcomes in mechanically ventilated patients during the COVID-19 pandemic: The COVID-SED study (2022) (0)
955: FLUID BALANCE IN THE ICU – INTERVENTIONS TO MINIMIZE FLUIDS IN PATIENTS WITH SEPTIC SHOCK (2014) (0)
Increased Mortality in Patients Without Ventilator-Associated Pneumonia: Response (2010) (0)
HEALTHCARE-ASSOCIATED BACTEREMIA: A DISTINCT CONCEPT (2009) (0)
Book Review Principles and Practice of Mechanical Ventilation Second edition. Edited by Martin J. Tobin. 1442 pp., illustrated. New York, McGraw-Hill, 2006. $189.95. 978-0-07-144767-6 (2007) (0)
HEALTHCARE ASSOCIATED PNEUMONIA, INITIAL CHOICE OF ANTIMICROBIAL THERAPY AND OUTCOMES AMONG PATIENTS HOSPITALIZED WITH PNEUMONIA IN THE PRESENCE AND ABSENCE OF RESPIRATORY FAILURE (2008) (0)
INABILITY TO PREDICT ETIOLOGY IN FUNGEMIA IN THE ICU: IMPLICATIONS OF THE PREVALENCE OF NON-ALBICANS (NA) CANDIDEMIA.: 179-T (2005) (0)
60 Derivation and Validation of a Novel Hospital Capability Score for Sepsis (2023) (0)
A Prospective Analysis of the National Healthcare Safety Network (NHSN) Surveillance Algorithm for Ventilator-Associated Events (VAEs) (2013) (0)
A persistent left lower lobe infiltrate and chronic cough following chest wounds sustained in Vietnam twenty-four years earlier. (1993) (0)
Ten old antibiotics that will never disappear (2015) (0)
LONG-TERM EFFECTS OF SELECTIVE DECONTAMINATION AND ANTIMICROBIAL RESISTANCE. AUTHORS' REPLY (1996) (0)
The author replies. (2017) (0)
Association Between the Opening of a Dedicated Oncology Intensive Care Unit and Clinical Outcomes Among Hospitalized Patients with Cancer (2021) (0)
PIN51 HOSPITAL LENGTH OF STAY AND COSTS ASSOCIATED WITH INAPPROPRIATE TREATMENT OF CANDIDEMIA IN THE ICU (2009) (0)
705: USE OF A COMMON CANISTER METERED DOSE INHALER PROTOCOL IN MECHANICALLY VENTILATED PATIENTS (2015) (0)
10: THE SUSTAINABILITY OF LUNG-PROTECTIVE VENTILATION IN THE ED: A 5-YEAR, SINGLE-CENTER EXPERIENCE (2021) (0)
Reply to Aliberti et al and van Griensven et al (2012) (0)
60: BEFORE-AFTER COMPARISON OF A SEDATION PROTOCOL MINIMIZING BENZODIAZEPINE INFUSIONS AND FAVORING EARLY DEXMEDETOMIDINE (2012) (0)
The Impact of An Antibiotic Discontinuation Protocol of the Duration of Therapy for Ventilator-associated Pneumoni (2003) (0)
Effect of Early Administration of Vasopressin on New-Onset Arrhythmia Development in Patients With Septic Shock: A Retrospective, Observational Cohort Study. (2021) (0)
The authors reply. (2016) (0)
414: INHALED EPOPROSTENOL FOR ARDS (2013) (0)
Continuous IV Sedation and Prolonged Mechanical Ventilation (1999) (0)
346: EXAMINING THE INFLUENCE OF SOCIAL, SOCIOECONOMIC, AND MEDICAL HISTORIES ON SEPSIS-RELATED MORTALITY (2019) (0)
619: OUTCOMES OF MACROLIDE DE-ESCALATION IN SEVERE COMMUNITY- ACQUIRED PNEUMONIA (2020) (0)
DEFINING SEVERITY IN SOFT TISSUE INFECTIONS (2017) (0)
1090: SEDATIVES, DEEP SEDATION, AND COMA IN MECHANICALLY VENTILATED AIR TRANSPORT PATIENTS: A COHORT STUDY (2021) (0)
Modulates Early Inflammatory Responses During H 5 N 1 Influenza Infection (2016) (0)
IDENTIFICATION OF PATIENT CLUSTERS USING APACHE II PARAMETERS, AND THEIR CORRELATION TO OUTCOMES (1999) (0)
1460: EPIDEMIOLOGY AND OUTCOMES OF SEPSIS-ASSOCIATED COAGULOPATHY IN SEVERE SEPSIS AND SEPTIC SHOCK (2016) (0)
987: LUNG-PROTECTIVE VENTILATION IN THE EMERGENCY DEPARTMENT REDUCES MORTALITY IN PATIENTS WITH ARDS (2016) (0)
SurvivalClinical Response and 28-Day Telavancin for Hospital-Acquired (2014) (0)
Correctly scoring infections: CSI in the ICU. (2007) (0)
242: AN EPIDEMIOLOGIC AND RACIAL DISPARITY EVALUATION OF CONTINUOUS INFUSION SEDATION IN THE ICU (2022) (0)
Use of Enteral Phenobarbital in ICU Patients with Refractory Agitation: A Case Series (2019) (0)
The Impact of Antibiotic Resistance in Patients With Septic Shock Treated With Appropriate Antimicrobial Therapy (2011) (0)
1008. Cluster Analysis to Define Distinct Clinical Phenotypes Among Septic Patients With Bloodstream Infections (2018) (0)
NOSOCOMIAL BACTEREMIA AND SEPSIS: EPIDEMIOLOGY, OUTCOMES, AND COST: 545 (2004) (0)
Comprar The Washington Manual of Critical Care | Warren Isakow MD | 9781451193879 | Lippincott Williams & Wilkins (2013) (0)
Book Review Sepsis and Multiorgan Failure Edited by Alan M. Fein, with six others. 675 pp., illustrated. Baltimore, Williams & Wilkins, 1997. $99. 0-683-03097-3 (1998) (0)
1477. Impact Of Resistance Thresholds On Mortality In Hospital-Acquired And Ventilator-Associated Pneumonia (2020) (0)
The Flood and Ebb of Septic Shock: Response (2009) (0)
Determinants of Mortality for Ventilated Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia (2023) (0)
RATES AND OUTCOMES OF CLOSTRIDIUM DIFFICILE-ASSOCIATED DISEASE (CDAD) AMONG PATIENTS ON PROLONGED ACUTE MECHANICAL VENTILATION (PAMV) (2008) (0)
485: CUMULATIVE ANTIBIOTIC SPECTRUM SCORES AND THE RISK OF SUPERINFECTION: PRELIMINARY RESULTS (2022) (0)
Azithromycin and Mortality in Streptococcus pneumoniae Pneumonia (2012) (0)
Standardization of Care to Improve Outcomes of Patients with Ventilator-associated Pneumonia and Severe Sepsis (2010) (0)
PIN61 Bacteriology and Inappropriate Empiric Therapy in Mixed Complicated Skin and Skin Structure Infections (2012) (0)
1658C. difficile Recurrence is a Strong Predictor of 30-day Rehospitalization Among ICU Patients (2014) (0)
Relationship Between Microbiological Eradication and Clinical Outcome with Antibiotic Treatment in Nosocomial Pneumonia, Complicated Urinary Tract Infection, and Complicated Intra-Abdominal Infection. (2014) (0)
STROKE VOLUME MEASUREMENT BY NON-INVASIVE DOPPLER IN CONJUNCTION WITH PASSIVE LEG RAISING PREDICTS FLUID RESPONSIVENESS IN MEDICAL INTENSIVE CARE UNIT PATIENTS (2008) (0)
Rebuttal From Drs Aguilar and Kollef. (2019) (0)
The authors reply [19] (2006) (0)

This paper list is powered by the following services:

Marin H. Kollef's Academic­Influence.com Rankings

Marin H. Kollef's Degrees

Why Is Marin H. Kollef Influential?

Marin H. Kollef's Published Works

Published Works

Marin H. Kollef's AcademicInfluence.com Rankings